Recombinant Mouse Anti-SIGLEC9 Antibody (MM0552-6K12)

CAT#: NEUT-1964CQ

This antibody is a mouse monoclonal antibody that binds specifically to SIGLEC9, and it can neutralize the bioactivity of SIGLEC9.

Gene Expression
Figure 1 IHC staining of human spleen Figure 2 Cerebral cortex Figure 3 Colon Figure 4 Liver Figure 5 Testis Figure 6 Spleen Figure 7 RNA cell line category: Group enriched (Karpas-707, RPMI-8226)

Specifications

  • Immunogen
  • Recombinant fragment of Human SIGLEC9 extracellular domain.
  • Host Species
  • Mouse
  • Type
  • IgG2
  • Specificity
  • Recognizes SIGLEC9
  • Species Reactivity
  • Human
  • Clone
  • MM0552-6K12
  • Applications
  • Used for immunoassay techniques such as: Western Blot; Neutralization
  • Conjugate
  • Unconjugated

Product Property

  • Purification
  • Protein G purified
  • Purity
  • >95% as determined by analysis by SDS-PAGE
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze-thaw cycles.

Target

  • Alternative Names
  • SIGLEC9; sialic acid binding Ig like lectin 9; CD329; CDw329; FOAP-9; siglec-9; OBBP-LIKE
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for NEUT-1964CQ. Click the button above to contact us or submit your feedback about this product.
Breast cancer biomarkers at key points during disease progression
Exceptional Specificity
The anti-SIGLEC9 antibody has significantly enhanced the precision of my immunofluorescence experiments. Its exceptional specificity allowed me to visualize SIGLEC9 localization within single cells accurately, without background interference. This precision was crucial for quantifying expression levels in heterogeneous cell populations. The reliable data obtained contributed to a deeper understanding of SIGLEC9's role in immune cell signaling, leading to a pivotal advancement in my research project.
Breast cancer biomarkers at key points during disease progression
Streamlined Workflow Efficiency
Incorporating this antibody into our protocols has greatly simplified our workflow. Its ease of use and consistent performance have reduced the time spent on troubleshooting and optimization. The simplified operation steps have allowed our team to focus more on data analysis and less on technical issues, improving overall laboratory efficiency and productivity.
Breast cancer biomarkers at key points during disease progression
Outstanding Technical Support
The supplier's technical support has been highly professional and responsive. Any inquiries we had were promptly addressed with in-depth knowledge and practical solutions. This level of service provided us with confidence and assurance, knowing that expert assistance was readily available whenever needed, which is a significant advantage in fast-paced research environments.

Q&As

  1. How does the anti-SIGLEC9 antibody facilitate research into the role of SIGLEC9 in cancer progression?

    A: SIGLEC9 is known to modulate immune responses and has been implicated in tumor immune evasion mechanisms. The anti-SIGLEC9 antibody enables researchers to investigate the expression levels and functional status of SIGLEC9 in tumor cells and immune cells within the tumor microenvironment. By detecting SIGLEC9 expression patterns, the antibody helps elucidate how tumors may exploit SIGLEC9-mediated pathways to suppress immune surveillance. This understanding can lead to the development of new immunotherapeutic strategies targeting SIGLEC9 interactions in cancer treatment.

  2. What are the unique structural and functional characteristics of the SIGLEC9 epitope recognized by the anti-SIGLEC9 antibody, and how does this interaction influence protein networks?

    A: The anti-SIGLEC9 antibody targets a specific extracellular epitope on SIGLEC9 characterized by a unique sequence and conformation critical for ligand binding. This precise targeting allows the antibody to bind without interfering with other siglec family members. The interaction can modulate SIGLEC9's role in cell signaling by blocking ligand engagement or altering receptor conformation. This affects downstream protein-protein interactions within signaling networks, potentially influencing processes like cell adhesion, migration, and immune response modulation.

  3. What stability characteristics does the antibody exhibit under various storage conditions and environmental factors?

    A: The antibody exhibits excellent stability across a range of storage conditions, including prolonged periods at refrigeration and freezing temperatures. It maintains its functional integrity after multiple freeze-thaw cycles and remains effective even when stored at room temperature for short durations. Additionally, the antibody shows resilience to variations in humidity and pH levels, ensuring consistent performance in diverse laboratory environments. This stability reduces degradation risks and enhances the reproducibility of experimental results over time.

View the frequently asked questions answered by Creative Biolabs Support.

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

See other products for "SIGLEC9"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
NEUT-1963CQ Recombinant Mouse Anti-SIGLEC9 Antibody (CBL273) FC, ELISA, WB, Neut IgG2a
NEUT-1965CQ Recombinant Mouse Anti-SIGLEC9 Antibody (CBL164) Neut, WB IgG2
NEUT-1966CQ Recombinant Mouse Anti-SIGLEC9 Antibody (CBL711) WB, FC, CyTOF, ELISA(Cap), Neut IgG2a
CAT Product Name Application Type
VS-1024-XY479 Mouse Anti-NHP SIGLEC9 Recombinant Antibody (clone OTI6D8) WB, IHC, ICC Mouse IgG1
CAT Product Name Application Type
VS-0425-YC471 Recombinant Anti-SIGLEC9 Vesicular Antibody, EV Displayed (VS-0425-YC471) Cyt, ELISA, FC, Neut, Cell-uptake
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare